The Oncologist, 1083-7159


  1. 2020
  2. Koopman, B., Groen, H. J. M., Ligtenberg, M. J. L., Grünberg, K., Monkhorst, K., de Langen, A. J., Boelens, M. C., Paats, M. S., Von der Thüsen, J. H., Dinjens, W. N. M., Solleveld, N., Van Wezel, T., Gelderblom, H., Hendriks, L. E., Speel, E-J. M., Theunissen, T. E., Kroeze, L. I., Mehra, N., Piet, B., ... van Kempen, L. (2020). Multicenter comparison of Molecular Tumor Boards in the Netherlands: definition, composition, methods and targeted therapy recommendations. The Oncologist.
  3. Italian Germ Cell Cancer Group (IGG), Nappi, L., Ottaviano, M., Rescigno, P., Tortora, M., Banna, G. L., Baciarello, G., Basso, U., Canil, C., Cavo, A., Cossu Rocca, M., Czaykowski, P., De Giorgi, U., Garcia Del Muro, X., Di Napoli, M., Fornarini, G., Gietema, J. A., Heng, D. Y. C., Hotte, S. J., ... Palmieri, G. (2020). Management of Germ Cell Tumors During the Outbreak of the Novel Coronavirus Disease-19 Pandemic: A Survey of International Expertise Centers. The Oncologist, 25(10), 1-7.
  4. Looijaard, S. M. L. M., Meskers, C. G. M., Slee-Valentijn, M. S., Bouman, D. E., Wymenga, A. N. M., Klaase, J. M., & Maier, A. B. (2020). Computed Tomography-Based Body Composition Is Not Consistently Associated with Outcome in Older Patients with Colorectal Cancer. The Oncologist, 25(3), e492-e501.
  5. 2019
  6. Lipplaa, A., Kroep, J. R., van der Heijden, L., Jutte, P. C., Hogendoorn, P. C. W., Dijkstra, S., & Gelderblom, H. (2019). Adjuvant Zoledronic Acid in High-Risk Giant Cell Tumor of Bone: A Multicenter Randomized Phase II Trial. The Oncologist, 24(7), 889-e421.
  7. 2018
  8. Salazar, R., Garcia-Carbonero, R., Libutti, S. K., Hendifar, A. E., Custodio, A., Guimbaud, R., Lombard-Bohas, C., Ricci, S., Klumpen, H-J., Capdevila, J., Reed, N., Walenkamp, A., Grande, E., Safina, S., Meyer, T., Kong, O., Salomon, H., Tavorath, R., & Yao, J. C. (2018). Phase II Study of BEZ235 versus Everolimus in Patients with Mammalian Target of Rapamycin Inhibitor-Naive Advanced Pancreatic Neuroendocrine Tumors. The Oncologist, 23(7), 766-e90.
  9. Postmus, D., Richard, S., Bere, N., van Valkenhoef, G., Galinsky, J., Low, E., Moulon, I., Mavris, M., Salmonsson, T., Flores, B., Hillege, H., & Pignatti, F. (2018). Individual Trade-Offs Between Possible Benefits and Risks of Cancer Treatments: Results from a Stated Preference Study with Patients with Multiple Myeloma. The Oncologist, 23(1), 44-51.
  10. 2017
  11. Bins, S., Cirkel, G. A., Gadellaa-Van Hooijdonk, C. G., Weeber, F., Numan, I. J., Bruggink, A. H., van Diest, P. J., Willems, S. M., Veldhuis, W. B., van den Heuvel, M. M., de Knegt, R. J., Koudijs, M. J., van Werkhoven, E., Mathijssen, R. H. J., Cuppen, E., Sleijfer, S., Schellens, J. H. M., Voest, E. E., Langenberg, M. H. G., ... Lolkema, M. P. (2017). Implementation of a Multicenter Biobanking Collaboration for Next-Generation Sequencing-Based Biomarker Discovery Based on Fresh Frozen Pretreatment Tumor Tissue Biopsies. The Oncologist, 22(1), 33-40.
  12. 2016
  13. 2014
  14. 2012
  15. 2011
  16. Verdegaal, S. H. M., Bovee, J. V. M. G., Pansuriya, T. C., Grimer, R. J., Ozger, H., Jutte, P. C., San Julian, M., Biau, D. J., van der Geest, I. C. M., Leithner, A., Streitbuerger, A., Klenke, F. M., Gouin, F. G., Campanacci, D. A., Marec-Berard, P., Hogendoorn, P. C. W., Brand, R., & Taminiau, A. H. M. (2011). Incidence, Predictive Factors, and Prognosis of Chondrosarcoma in Patients with Ollier Disease and Maffucci Syndrome: An International Multicenter Study of 161 Patients. The Oncologist, 16(12), 1771-1779.
  17. 2010
  18. Wessels, H., de Graeff, A., Wynia, K., de Heus, M., Kruitwagen, C. L. J. J., Woltjer, G. T. G. J., Teunissen, S. C. C. M., & Voest, E. E. (2010). Gender-related needs and preferences in cancer care indicate the need for an individualized approach to cancer patients. The Oncologist, 15(6), 648-655.
  19. Goedendorp, M. M., Peters, M. E. W. J., Gielissen, M. F. M., Witjes, J. A., Leer, J. W., Verhagen, C. A. H. H. V. M., & Bleijenberg, G. (2010). Is increasing physical activity necessary to diminish fatigue during cancer treatment? The Oncologist, 15(10), 1122-1132.
  20. 2008
  21. 2007
  22. 2006

ID: 2858401